Introducing

Next-Generation Injectable Hyaluronic Acid Utilizing Cold-X™ Technology

Evolysse™ is a next-generation collection of injectable hyaluronic acid gels made with Cold-X Technology, a novel manufacturing step aimed at preserving the natural HA structure.

Sign up for exclusive Updates

Are you ready for something new?

The First Advanced Injectable Hyaluronic Acid Technology Launched in a Decade

Evolysse is the next-generation injectable hyaluronic acid made with Cold-X Technology. The Evolysse collection launches with two injectable HA gels, each with unique viscoelastic properties, to soften wrinkles that form in dynamic areas of the face, such as the nasolabial folds.

An Established Safety& Efficacy Profile*

Evolysse Form and Evolysse Smooth were studied in a prospective, randomized controlled, multi-center study to establish the safety and effectiveness in the treatment of nasolabial folds.

In the head-to-head clinical study versus Restylane-L, there were no delayed onset nodules with Evolysse Form or Evolysse Smooth.

Results last 12 months.**

*Evolysse Form and Evolysse Smooth Directions for Use.
**In most patients with optimal correction.

Designed to achieve a range
of treatment goals

The Evolysse collection launches in 2025 with two injectable hyaluronic acid gels, each with unique viscoelastic properties to soften wrinkles that form in dynamic areas of the face such as the nasolabial folds.

Evolysse Form

Treatment Goal: For lift and support

Evolysse Smooth

Treatment Goal: For a soft and smooth result

Sign up for Exclusive Updates
Sign up for exclusive Updates

Evolus is excited to introduce Evolysse

made with Cold-X Technology

Hand holding medical syringe.

Developed by global hyaluronic acid expert

Cold-X Technology was studied, developed and enhanced by industry leader Symatese, renowned for introducing many of the leading technologies used in medical aesthetics today. Symatese is well established, having developed the latest generation of Restylane® products in the U.S. based on XpresHAn Technology™/OBT® in addition to products by Mentor and L’Oreal.

Evolus evaluated multiple hyaluronic acid technologies, seeking the most innovative technology provider
before entering into a licensing agreement with Symatese in 2023.

Evolysse Form and Evolysse Smooth product display boxes.

Get on the list

Sign up to be among the first to learn about our upcoming launch and additional Evolysse education.

Sign up for Exclusive Updates
Sign up for exclusive Updates